We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Immunome Inc | NASDAQ:IMNM | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.28 | 1.90% | 14.99 | 15.03 | 15.20 | 15.81 | 14.61 | 15.32 | 1,588,124 | 01:00:00 |
| | |
Page
|
| |||
| | | | S-ii | | | |
| | | | S-1 | | | |
| | | | S-3 | | | |
| | | | S-4 | | | |
| | | | S-6 | | | |
| | | | S-7 | | | |
| | | | S-8 | | | |
| | | | S-10 | | | |
| | | | S-11 | | | |
| | | | S-11 | | | |
| | | | S-11 | | | |
| | | | S-11 | | |
| | |
Page
|
| |||
| | | | ii | | | |
| | | | 1 | | | |
| | | | 5 | | | |
| | | | 6 | | | |
| | | | 7 | | | |
| | | | 8 | | | |
| | | | 12 | | | |
| | | | 19 | | | |
| | | | 22 | | | |
| | | | 25 | | | |
| | | | 27 | | | |
| | | | 28 | | | |
| | | | 29 | | | |
| | | | 30 | | |
|
Assumed public offering price per share
|
| | | | | | | | | $ | 15.50 | | |
|
Historical net tangible book value per share as of March 31, 2024
|
| | | $ | 4.78 | | | | | | | | |
|
Increase per share attributable to new investors
|
| | | $ | 1.82 | | | | | | | | |
|
As adjusted net tangible book value per share after giving effect to this offering
|
| | | | | | | | | $ | 6.60 | | |
|
Dilution in adjusted net tangible book value per share to new investors
|
| | | | | | | | | $ | 8.90 | | |
| | | | | ii | | | |
| | | | | 1 | | | |
| | | | | 5 | | | |
| | | | | 6 | | | |
| | | | | 7 | | | |
| | | | | 8 | | | |
| | | | | 12 | | | |
| | | | | 19 | | | |
| | | | | 22 | | | |
| | | | | 25 | | | |
| | | | | 27 | | | |
| | | | | 28 | | | |
| | | | | 29 | | | |
| | | | | 30 | | |
Exhibit 107
Calculation of Filing Fee Tables
Form S-3
(Form Type)
Immunome, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
Security Type |
Security Class Title |
Fee Calculation or Carry Forward Rule |
Amount Registered(1) |
Proposed Maximum Offering Price Per Unit(2) |
Maximum Aggregate Offering Price |
Fee Rate | Amount of Registration Fee(3) |
Carry Forward Form Type |
Carry Forward File Number |
Carry Forward Initial Effective Date |
Filing Fee Previously Paid In Connection with Securities Forward(4) | |
Newly Registered Securities | ||||||||||||
Fees to be Paid | Equity | Common stock, par value $0.0001 per share | 457(o) | — | — | $35,550 | .00014760 | $5.25 | ||||
Fees Previously Paid | — | — | — | — | — | — | — | — | ||||
Carryforward Securities | ||||||||||||
Carry Forward Securities | Equity | Common stock, par value $0.0001 per share | 415(a)(6) | — | $199,964,450 | S-3 | 333-259966 | October 14, 2021 | $18,536.70 | |||
Total Offering Amounts | $200,000,000 | $5.25 | ||||||||||
Total Fees Previously Paid | — | |||||||||||
Total Fee Offsets | — | |||||||||||
Net Fee Due | $5.25 |
(1) | Consists of shares to be issued pursuant to that Sales Agreement, dated May 14, 2024, by and between the registrant and TD Securities (USA) LLC. |
(2) | The proposed maximum offering price per security will be determined from time to time by the registrant in connection with the issuance by the registrant of the securities registered hereunder and is not specified as to each class of security pursuant to General Instruction II.D of Form S-3 under the Securities Act of 1933, as amended (the “Securities Act”). |
(3) | Calculated in accordance with Rule 457(o) and Rule 457(r) under the Securities Act. Represents payment of registration fees previously deferred in connection with the Registration Statement on Form S-3ASR (Registration No. 333-277036). |
(4) |
Pursuant to Rule 415(a)(6) under the Securities Act, the securities registered pursuant to this registration statement include $199,964,450 of unsold securities (the “Unsold Securities”) previously registered and offered by the registrant pursuant to the Registration Statement on Form S-3 (File No. 333-259966), which was declared effective on October 14, 2021 (the “Prior Registration Statement”). In connection with the filing of the Prior Registration Statement, the registrant paid a filing fee of $18,540 (based on the filing fee rate in effect at the time of the filing of the Prior Registration Statement). Of this amount, $18,536.70 is associated with the Unsold Securities. The filing fee associated with the offering of the Unsold Securities is hereby carried forward to be applied to the Unsold Securities registered hereunder, and no additional filing fee is due with respect to the Unsold Securities in connection with the filing of this registration statement.
To the extent that, after the filing date hereof and prior to the effectiveness of this registration statement, the registrant sells any Unsold Securities pursuant to the Prior Registration Statement, the registrant will identify in a pre-effective amendment to this registration statement the updated dollar amount of Unsold Securities from the Prior Registration Statement to be included in this registration statement pursuant to Rule 415(a)(6) and/or Rule 457(p) and the updated amount of new securities to be registered on this registration statement. Pursuant to Rule 415(a)(6) and Rule 457(p), the offering of securities under the Prior Registration Statement will be deemed terminated as of the date of effectiveness of this registration statement. |
1 Year Immunome Chart |
1 Month Immunome Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions